IFP Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.9K Hold
1,250
﹤0.01% 2430
2026
Q1
$26.5K Buy
1,250
+1
+0.1% +$20 ﹤0.01% 2621
2025
Q4
$20.4K Buy
1,249
+17
+1% +$257 ﹤0.01% 2720
2025
Q3
$14.4K Hold
1,232
﹤0.01% 2735
2025
Q2
$14.3K Buy
1,232
+939
+320% +$8.56K ﹤0.01% 2726
2025
Q1
$2.56K Sell
293
-229
-44% -$2.89K ﹤0.01% 3067
2024
Q4
$7.5K Buy
522
+381
+270% +$6.01K ﹤0.01% 2651
2024
Q3
$3.18K Buy
141
+108
+327% +$2.23K ﹤0.01% 2799
2024
Q2
$642 Buy
33
+5
+18% +$131 ﹤0.01% 3064
2024
Q1
$1.05K Hold
28
﹤0.01% 2861
2023
Q4
$1.57K Hold
28
﹤0.01% 2734
2023
Q3
$1.16K Hold
28
﹤0.01% 2971
2023
Q2
$1.56K Hold
28
﹤0.01% 2957
2023
Q1
$1.48K Sell
28
-46
-62% -$2.15K ﹤0.01% 2984
2022
Q4
$4K Sell
74
-97
-57% -$3.17K ﹤0.01% 3937
2022
Q3
$14K Buy
171
+2
+1% +$76 ﹤0.01% 3416
2022
Q2
$14K Hold
169
﹤0.01% 3166
2022
Q1
$14K Buy
169
+134
+383% +$11.7K ﹤0.01% 3166
2021
Q4
$5K Buy
35
+7
+25% +$1.07K ﹤0.01% 2516
2021
Q3
$4K Hold
28
﹤0.01% 2664
2021
Q2
$5K Buy
+28
New +$5.07K ﹤0.01% 2497
2020
Q4
Sell
-10
Closed -$1.45K 3098
2020
Q3
$1K Buy
+10
New +$1.05K ﹤0.01% 2727
2020
Q1
Sell
-600
Closed -$46.8K 3012
2019
Q4
$47K Buy
+600
New +$36.1K ﹤0.01% 1288

Other funds holding TXG

IFP Advisors's TXG Position: Q2 2026 in Review

IFP Advisors held its 10x Genomics (TXG) position steady in Q2 2026 at 1,250 shares worth $47.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

IFP Advisors first reported a position in TXG in Q4 2019 and has held it in 23 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • IFP Advisors held 1,250 shares of 10x Genomics worth $47.9K as of Q2 2026.
  • IFP Advisors left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2430 holding.
  • IFP Advisors first reported a position in 10x Genomics in Q4 2019 and has held it in 23 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.